The efficacy and adverse events of arsenic trioxide for the patients with myelodysplastic syndrome: a systematic review and component network meta-analysis

CONCLUSION: ATO may be an effective and well-tolerant option for patients with myelodysplastic syndrome.PMID:37908176 | DOI:10.1080/16078454.2023.2274149

Source: Hematology - November 1, 2023 Category: Hematology Authors: Xiaohua Huang Yuan Liu Ruixuan Liu Xiaoqiu Zou Hongyong Yang Source Type: research